Amplyx Pharmaceuticals Funding & Investors
Amplyx Pharmaceuticals, Inc. operates as a small molecule drug development company. It develops oral and injectable anti-infective drugs, including protease inhibitors and antibiotics.
amplyx.comTotal Amount Raised: $198,370,000
Amplyx Pharmaceuticals Funding Rounds
Series C
$53,000,000
Series C Investors
Arix BioscienceNew Enterprise Associates (NEA)Pappas CapitalSofinnovaAdage Capital Management3x5 PartnersLundbeckfondenBioMed VenturesPfizerRiverVest Venture ManagementDebt Financing
$14,700,000
Debt Financing
$12,970,000
Series C
$67,000,000
Series C Investors
Arix BioscienceNew Enterprise Associates (NEA)3x5 Special Opportunity FundPappas CapitalSofinnovaLundbeckfondenBioMed VenturesRiverVest Venture ManagementGeneration VenturesSeries B
$8,700,000
Series B Investors
3x5 Special Opportunity FundSeries B
$40,500,000
Series B Investors
New Enterprise Associates (NEA)BioMed VenturesRiverVest Venture ManagementDebt Financing
$1,500,000
Funding info provided by Diffbot.